Gestation and COVID-19: clinical and microbiological study (GESTA-COVID19)

Objective: The main objective of this study is to describe the influence of pregnancy on COVID-19 infection, as well as the influence of COVID-19 (and its treatment) on pregnancy, the fetus and the newborn. Methods: This is a descriptive, observational longitudinal and multicenter study consisting of 8 hospitals: H. U. Vall d'Hebron (Barcelona) and H.U. La Paz (Madrid), H.U. Virgen de la Arrixaca (Murcia), H.U. Cruces (Bizkaia) and H.U.C. Lozano Blesa (Zaragoza), San Cecilio University Hospital (Granada), H.U. La Fe (Valencia), H.U. Torrejón (Madrid). It will take place between April 2020 and March 2021. An electronic data collection notebook (REDCap) will be designed where the data will be entered anonymously. Pregnant women infected with SARS-CoV-2 will be included, microbiological samples from the mother and the newborn will be collected and processed (PCR-SARS-CoV-2 in a delayed manner) and clinical data related to the patient, the infection, its treatment and complications. , pregnancy and complications, childbirth and the newborn. The results will be disclosed to the scientific community, society and health authorities.